Return to Search

NRG GI005 Phase II/III Study of Circulating Tumor DNA as a Predictive Biomarker in Adjuvant Chemotherapy in Patients with Stage IIA Colon Cancer (COBRA)

Start Date: January 19, 2021

IRB Number: https://www.clinicaltrials.gov/ct2/show/NCT04068103

Condition/Disease: Cancer - Colorectal

Principal Investigator: Eleanor M Walker, MD

Purpose of Research: CANCER, COLON, COLON CANCER

Status: Accepting Participants

Phone: (313) 916-1784

Email

Filter Results